Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 75 entries
View as:

Anesthesia in PROstate Biopsy Pain Obstruction Study

Phase: N/A Priority: Normal
NCT ID: NCT04501055 Org: User:
Start: 08/13/20 End: 07/27/22 Due: 07/27/23

Effect of Human Umbilical Cord-derived Mesenchymal Stem Cells on Non-cardiac Surgery-induced Lung Injury

Phase: N/A Priority: Normal
NCT ID: NCT04996966 Org: User:
Start: 08/01/21 End: 12/31/23 Due: 12/31/24

Comparison H-FIRE and Laparoscopic RP in Treating Men With Localized Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04278261 Org: User:
Start: 07/01/22 End: 09/01/26 Due: 09/01/27

Catheter in the Prevention of Urinary Tract Infections and Crystallization Study(CPUTICS)

Phase: N/A Priority: Normal
NCT ID: NCT06230042 Org: User:
Start: 02/01/24 End: 02/15/24 Due: 02/15/25

A Clinical Study to Observe the Safety and Efficacy of ScTIL210 in the Treatment of Malignant Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04571892 Org: User:
Start: 10/15/20 End: 12/31/24 Due: 12/31/25

Clinical Study of Umbilical Cord Mesenchymal Stem Cells in the Treatment of Type 2 Diabetic Nephropathy

Phase: N/A Priority: Normal
NCT ID: NCT04216849 Org: User:
Start: 07/01/20 End: 07/01/22 Due: 07/01/23

The Application of 68Ga-Pentixafor Alongside 68Ga-FAPI-04 PET/MR for Assessing Primary Aldosteronism.

Phase: N/A Priority: Normal
NCT ID: NCT06756737 Org: User:
Start: 01/01/25 End: 12/31/27 Due: 12/31/28

A Clinical Trial of Parkinson's Disease Treatment by HiPSCs Derived Dopaminergic Neural Precursor Cells

Phase: N/A Priority: Normal
NCT ID: NCT06145711 Org: User:
Start: 11/23/23 End: 12/22/25 Due: 12/22/26

Biparametric MRI in Prostate Cancer Screening: a Noninferior Randomized Controlled Study

Phase: N/A Priority: Normal
NCT ID: NCT05025527 Org: User:
Start: 12/01/22 End: 12/01/24 Due: 12/01/25

Autonomous Regulatory Monocytes (OPM Cells) for the Treatment of Diabetic Foot in a Single-arm Open-label Clinical Study

Phase: N/A Priority: Normal
NCT ID: NCT06621303 Org: User:
Start: 10/31/24 End: 10/31/25 Due: 10/31/26

Stereotactic Transplantation of hAESCs for Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT04414813 Org: User:
Start: 10/08/20 End: 02/08/23 Due: 02/08/24

Clinical Study of Granulocyte Infusion for Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04124666 Org: User:
Start: 12/01/19 End: 09/30/22 Due: 09/30/23

Effect of In-Place Slow Jogging on Metabolic Dysfunction-Associated Steatotic Liver Disease

Phase: N/A Priority: Normal
NCT ID: NCT06994234 Org: User:
Start: 06/20/25 End: 06/20/28 Due: 06/20/29

Bismuth Quadruple Therapy With Cefuroxime for Helicobacter Pylori Eradication Treatment

Phase: N/A Priority: Normal
NCT ID: NCT04723472 Org: User:
Start: 08/01/23 End: 12/31/25 Due: 12/31/26

Repeat Intravenous Infusions of B4T2-001 CAR-T Without Lymphodepleting Chemotherapy for Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06072989 Org: User:
Start: 10/31/23 End: 03/31/27 Due: 03/31/28

Early Initiated Ambulance-delivered Levetiracetam and Headposition in Hyper-acute Stroke Trial

Phase: N/A Priority: Normal
NCT ID: NCT06773364 Org: User:
Start: 04/30/25 End: 12/31/29 Due: 12/31/30

Efficacy and Safety of One-Stage Hybrid Coronary Revascularization

Phase: N/A Priority: Normal
NCT ID: NCT04811586 Org: User:
Start: 12/30/20 End: 12/01/23 Due: 12/01/24

A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of LCAR-M23, a CAR-T Cell Therapy Targeting MSLN in Patients With Relapsed and Refractory Epithelial Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04562298 Org: User:
Start: 10/21/20 End: 06/07/22 Due: 06/07/23

Erythropoietin and Iron Supplementation for Patients With Chemotherapy-induced Anaemia

Phase: N/A Priority: Normal
NCT ID: NCT02731378 Org: User:
Start: 12/31/16 End: 11/30/19 Due: 11/30/20

The Predictive Value of Prostate Spherical Volume Ratio in Lower Urinary Tract Symptoms and Clinical Progression of Benign Prostatic Hyperplasia:A Single-center Paired Validating Confirmatory Study

Phase: N/A Priority: Normal
NCT ID: NCT06448533 Org: User:
Start: 09/10/22 End: 03/30/24 Due: 03/30/25

Combined Therapy of Photoelectric Instruments and Human Umbilical Cord Mesenchymal Stem Cells for Pigmentary Disorders

Phase: N/A Priority: Normal
NCT ID: NCT06911281 Org: User:
Start: 06/30/25 End: 12/31/27 Due: 12/31/28

An Observational Study of Inflammatory Bowel Disease (IBD) Patients With Non-alcoholic Fatty Liver Disease (NAFLD)

Phase: N/A Priority: Normal
NCT ID: NCT06939569 Org: User:
Start: 05/01/25 End: 12/01/27 Due: 12/01/28

The Diagnostic Efficacy and Lesion Detection Advantages of 18F-FDG PET/CT and Enhanced MRI in Hepatic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT06700564 Org: User:
Start: 12/01/24 End: 11/30/27 Due: 11/30/28

Posterior-line Treatment With Disitamab Vedotin Plus PD-1 in Advanced HER2-low Expressing Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06078982 Org: User:
Start: 06/06/23 End: 08/31/25 Due: 08/31/26

Clinical Study of Induced Pluripotent Stem Cells Derived Motor Neuron Precursor Cell Therapy for Amyotrophic Lateral Sclerosis (ALS)

Phase: N/A Priority: Normal
NCT ID: NCT06765564 Org: User:
Start: 03/13/24 End: 05/13/25 Due: 05/13/26